BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23802843)

  • 21. Inhibition of hedgehog/Gli signaling by botanicals: a review of compounds with potential hedgehog pathway inhibitory activities.
    Drenkhahn SK; Jackson GA; Slusarz A; Starkey NJ; Lubahn DB
    Curr Cancer Drug Targets; 2013 Jun; 13(5):580-95. PubMed ID: 23675897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Artemisinin: a natural product for fighting against cancer].
    Takatani-Nakase T
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):61-4. PubMed ID: 24531897
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.
    Yeung AWK; El-Demerdash A; Berindan-Neagoe I; Atanasov AG; Ho YS
    Crit Rev Oncog; 2018; 23(5-6):347-370. PubMed ID: 30311565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumoral Properties of Natural Products.
    Fabiani R
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32028725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics.
    Comment LA; Ward AF; Schrock AB; Fabrizio D; Venstrom JM; Hegde PS; Alexander BM
    Clin Pharmacol Ther; 2020 Sep; 108(3):440-443. PubMed ID: 32744335
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.
    Youssoufian H
    IDrugs; 2010 Dec; 13(12):833-5. PubMed ID: 21154137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products, both small and large, and a focus on cancer treatment.
    McAlpine J; Romano A; Ecker D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):186-8. PubMed ID: 19333863
    [No Abstract]   [Full Text] [Related]  

  • 28. The Future of Precision Oncology for the Treatment of Solid Tumors.
    Klute KA
    Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular pathology in therapeutics: where are we now, and where are we going?
    Harrison DJ; Faratian D
    Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy.
    Rajagopal C; Lankadasari MB; Aranjani JM; Harikumar KB
    Pharmacol Res; 2018 Apr; 130():273-291. PubMed ID: 29305909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular targets in cancer therapy.
    Kummar S; Doroshow JH
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):267-9. PubMed ID: 23477512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 33. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
    Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
    Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
    Bao J; Qiao L
    Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural compounds for cancer treatment and prevention.
    Nobili S; Lippi D; Witort E; Donnini M; Bausi L; Mini E; Capaccioli S
    Pharmacol Res; 2009 Jun; 59(6):365-78. PubMed ID: 19429468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory and anticancer drugs from nature.
    Orlikova B; Legrand N; Panning J; Dicato M; Diederich M
    Cancer Treat Res; 2014; 159():123-43. PubMed ID: 24114478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimeric approaches to anti-cancer chemotherapeutics.
    Hadden MK; Blagg BS
    Anticancer Agents Med Chem; 2008 Oct; 8(7):807-16. PubMed ID: 18855582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural products against hematological malignancies and identification of their targets.
    Xu Y; Liu J; Wu Y; Guo Q; Sun H; Chen G
    Sci China Life Sci; 2015 Dec; 58(12):1191-201. PubMed ID: 26566803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytomedicine polypharmacology: Cancer therapy through modulating the tumor microenvironment and oxylipin dynamics.
    Apaya MK; Chang MT; Shyur LF
    Pharmacol Ther; 2016 Jun; 162():58-68. PubMed ID: 26969215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of natural products on developing new anti-cancer agents.
    Cragg GM; Grothaus PG; Newman DJ
    Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.